01 1ISOMEDIX
02 1Jubilant HollisterStier LLC
01 1Collagenase
02 1collagenase clostridium histolyticum
01 2U.S.A
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
NDC Package Code : 65044-7466
Start Marketing Date : 2010-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (0.9mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
NDC Package Code : 55718-150
Start Marketing Date : 2006-10-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
A Collagenase Clostridium Histolyticum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Collagenase Clostridium Histolyticum, including repackagers and relabelers. The FDA regulates Collagenase Clostridium Histolyticum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Collagenase Clostridium Histolyticum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Collagenase Clostridium Histolyticum supplier is an individual or a company that provides Collagenase Clostridium Histolyticum active pharmaceutical ingredient (API) or Collagenase Clostridium Histolyticum finished formulations upon request. The Collagenase Clostridium Histolyticum suppliers may include Collagenase Clostridium Histolyticum API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Collagenase Clostridium Histolyticum as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Collagenase Clostridium Histolyticum API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Collagenase Clostridium Histolyticum as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Collagenase Clostridium Histolyticum and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Collagenase Clostridium Histolyticum NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Collagenase Clostridium Histolyticum suppliers with NDC on PharmaCompass.
We have 2 companies offering Collagenase Clostridium Histolyticum
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
